Showing results (21-30 of 85) with videos related to
Sort By:
Pageof 9
Cancer Investigation|February 17, 2009
Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumorsGeoffrey Y Ku, Eileen M O'Reilly, Leonard B Saltz, et al.The Journal of Thoracic and Cardiovascular Surgery|August 9, 2002
A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: initial resultsManjit S Bains, Alexander Stojadinovic, Bruce Minsky, et al.American Journal of Clinical Oncology|April 22, 2009
Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validationMinaxi Jhawer, Daniel Coit, Murray Brennan, et al.Expert Review of Gastroenterology & Hepatology|February 17, 2016
Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approachesIbrahim H Sahin, Maeve A Lowery, Zsofia K Stadler, et al.Cancer Chemotherapy and Pharmacology|February 14, 2008
Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancerGeoffrey Y Ku, David H Ilson, Lawrence H Schwartz, et al.Investigational New Drugs|October 29, 2008
Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancerWilliam P Tew, Delia Radovich, Eileen O'Reilly, et al.Cancer|October 13, 2011
Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancerAndrew S Epstein, Gerald A Soff, Marinela Capanu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancerDavid H Ilson, Manjit Bains, David P Kelsen, et al.Annals of Surgical Oncology|October 3, 2007
Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?John C Mansour, Laura Tang, Manish Shah, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 12, 2011
MET expression and amplification in patients with localized gastric cancerYelena Y Janjigian, Laura H Tang, Daniel G Coit, et al.Pageof 9